These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 19198615)

  • 21. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
    Hong ZY; Yu SS; Wang ZJ; Zhu YZ
    Int J Mol Sci; 2015 Aug; 16(8):18544-63. PubMed ID: 26262618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.
    Arancibia S; Silhol M; Moulière F; Meffre J; Höllinger I; Maurice T; Tapia-Arancibia L
    Neurobiol Dis; 2008 Sep; 31(3):316-26. PubMed ID: 18585459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Parrado Fernandez C; Juric S; Backlund M; Dahlström M; Madjid N; Lidell V; Rasti A; Sandin J; Nordvall G; Forsell P
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease.
    Bomba M; Granzotto A; Castelli V; Onofrj M; Lattanzio R; Cimini A; Sensi SL
    J Alzheimers Dis; 2019; 70(3):793-810. PubMed ID: 31256135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
    Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
    Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.
    Braun DJ; Kalinin S; Feinstein DL
    ASN Neuro; 2017; 9(2):1759091417696161. PubMed ID: 28266222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
    Lim YY; Hassenstab J; Cruchaga C; Goate A; Fagan AM; Benzinger TL; Maruff P; Snyder PJ; Masters CL; Allegri R; Chhatwal J; Farlow MR; Graff-Radford NR; Laske C; Levin J; McDade E; Ringman JM; Rossor M; Salloway S; Schofield PR; Holtzman DM; Morris JC; Bateman RJ;
    Brain; 2016 Oct; 139(Pt 10):2766-2777. PubMed ID: 27521573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates.
    Nagahara AH; Wilson BR; Ivasyk I; Kovacs I; Rawalji S; Bringas JR; Pivirotto PJ; Sebastian WS; Samaranch L; Bankiewicz KS; Tuszynski MH
    Gene Ther; 2018 Apr; 25(2):104-114. PubMed ID: 29535375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.
    Liu XH; Geng Z; Yan J; Li T; Chen Q; Zhang QY; Chen ZY
    Neurobiol Dis; 2015 Feb; 74():377-91. PubMed ID: 25484286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astragaloside IV prevents Aβ
    Wang X; Xu W; Chen H; Li W; Li W; Zhu G
    Brain Res; 2020 Nov; 1747():147041. PubMed ID: 32739157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.
    Burbach GJ; Hellweg R; Haas CA; Del Turco D; Deicke U; Abramowski D; Jucker M; Staufenbiel M; Deller T
    J Neurosci; 2004 Mar; 24(10):2421-30. PubMed ID: 15014117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
    Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
    Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W; Feng Z; Xu J; Jiang Z; Feng M
    Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safflower Yellow Improves Synaptic Plasticity in APP/PS1 Mice by Regulating Microglia Activation Phenotypes and BDNF/TrkB/ERK Signaling Pathway.
    Pang J; Hou J; Zhou Z; Ren M; Mo Y; Yang G; Qu Z; Hu Y
    Neuromolecular Med; 2020 Sep; 22(3):341-358. PubMed ID: 32048142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.
    Simpkins JW; Green PS; Gridley KE; Singh M; de Fiebre NC; Rajakumar G
    Am J Med; 1997 Sep; 103(3A):19S-25S. PubMed ID: 9344403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor antagonist-mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF-H
    Chen L; Shi R; She X; Gu C; Chong L; Zhang L; Li R
    Fundam Clin Pharmacol; 2020 Dec; 34(6):697-707. PubMed ID: 32484999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.
    Kim J; Lee S; Choi BR; Yang H; Hwang Y; Park JH; LaFerla FM; Han JS; Lee KW; Kim J
    Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27735126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.